4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| LON | Laura McBain Vdeo - East Coast Australia Plans | 24/04/18 | 0 | 85 | |||
|
|||||||
| LON | SP 0.75 Floor?? | 23/04/18 | 3 | 975 | |||
|
|||||||
| LON | Bit of press today | 23/04/18 | 8 | 1.8K | |||
|
|||||||
| LON | Ann: Share Consolidation Update & Despatch of Holding Statements | 21/04/18 | 10 | 4.1K | |||
|
|||||||
| LON | Ann: Consolidation/Split - LON | 20/04/18 | 39 | 12K | |||
|
|||||||
| LON | Ann: Change of Director's Interest Notices x4 | 18/04/18 | 0 | 262 | |||
|
|||||||
| LON | Baby Formula and Organics | 18/04/18 | 3 | 1.6K | |||
|
|||||||
| LON | Ann: Security Trading Policy | 17/04/18 | 0 | 366 | |||
|
|||||||
See All Discussions
ASX News